Suppr超能文献

DRD2、DRD3和HTR2A单核苷酸多态性与非典型抗精神病药物的高治疗抗性有关。

DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs.

作者信息

Del Casale Antonio, Simmaco Maurizio, Modesti Martina Nicole, Zocchi Clarissa, Arena Jan Francesco, Bilotta Irene, Alcibiade Alessandro, Sarli Giuseppe, Cutillo Lorenzo, Antonelli Giulia, La Spina Enrico, De Luca Ottavia, Preissner Robert, Borro Marina, Gentile Giovanna, Girardi Paolo, Pompili Maurizio

机构信息

Department of Dynamic and Clinical Psychology and Health Studies, Faculty of Medicine and Psychology, Sapienza University of Rome, 00185 Rome, Italy.

Unit of Psychiatry, 'Sant'Andrea' University Hospital, 00189 Rome, Italy.

出版信息

Biomedicines. 2023 Jul 24;11(7):2088. doi: 10.3390/biomedicines11072088.

Abstract

BACKGROUND

The objective of this study was to investigate the rs1800497, rs1799732, rs1801028, rs6280, and rs6314, rs7997012, and rs6311 single-nucleotide polymorphism (SNP) correlations with resistance to second-generation antipsychotics (SGAs) in a real-world sample of patients with treatment-resistant mental disorders.

METHODS

We divided 129 participants into a high treatment resistance (HTR) group (current treatment with two SGAs, or clozapine, or classic neuroleptics for a failure of previous SGAs trials) and a low treatment resistance (LTR) group (current treatment with one atypical antipsychotic). We used Next-Generation Sequencing on DNA isolated from peripheral blood samples to analyze the polymorphisms. We performed logistic regression to search for predictors of HTR membership.

RESULTS

A diagnosis of schizophrenia significantly predicted the HTR membership compared to other diagnoses. Other predictors were the rs6280 C|T (OR = 22.195) and T|T (OR = 18.47) vs. C|C, rs7997012 A|G vs. A|A (OR = 6.859) and vs. G|G (OR = 2.879), and rs1799732 I|I vs. D|I (OR = 12.079) genotypes.

CONCLUSIONS

A diagnosis of schizophrenia and the rs1799732, rs6280, and rs7997012 genotypes can predict high treatment resistance to SGAs.

摘要

背景

本研究的目的是在治疗抵抗性精神障碍患者的真实样本中,调查rs1800497、rs1799732、rs1801028、rs6280、rs6314、rs7997012和rs6311单核苷酸多态性(SNP)与第二代抗精神病药物(SGA)耐药性的相关性。

方法

我们将129名参与者分为高治疗抵抗(HTR)组(目前使用两种SGA、氯氮平或经典抗精神病药物治疗,此前SGA试验失败)和低治疗抵抗(LTR)组(目前使用一种非典型抗精神病药物治疗)。我们对外周血样本中分离的DNA进行二代测序,以分析多态性。我们进行逻辑回归以寻找HTR组成员的预测因素。

结果

与其他诊断相比,精神分裂症诊断显著预测了HTR组成员身份。其他预测因素为rs6280 C|T(OR = 22.195)和T|T(OR = 18.47)与C|C相比、rs7997012 A|G与A|A相比(OR = 6.859)以及与G|G相比(OR = 2.879),以及rs1799732 I|I与D|I相比(OR = 12.079)基因型。

结论

精神分裂症诊断以及rs1799732、rs6280和rs7997012基因型可预测对SGA的高治疗抵抗性。

相似文献

4
The pharmacogenetics of treatment with olanzapine.奥氮平治疗的药物遗传学。
Pharmacogenomics. 2021 Sep;22(14):939-958. doi: 10.2217/pgs-2021-0051. Epub 2021 Sep 16.

本文引用的文献

3
Pharmacogenomics in treatment of depression and psychosis: an update.药物基因组学在抑郁症和精神病治疗中的应用:最新进展。
Trends Pharmacol Sci. 2022 Dec;43(12):1055-1069. doi: 10.1016/j.tips.2022.09.011. Epub 2022 Oct 25.
4
Bipolar depression: a review of treatment options.双相抑郁症:治疗选择综述
Gen Psychiatr. 2022 Aug 4;35(4):e100760. doi: 10.1136/gpsych-2022-100760. eCollection 2022.
10
The pharmacogenetics of treatment with olanzapine.奥氮平治疗的药物遗传学。
Pharmacogenomics. 2021 Sep;22(14):939-958. doi: 10.2217/pgs-2021-0051. Epub 2021 Sep 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验